A 72-year-old woman with cirrhosis (Child-Pugh C) and ascites presents with acute onset fever (38.8°C), abdominal pain, and altered mental status. On examination, she is hypotensive (BP 82/48 mmHg), tachycardic (HR 125/min), and icteric. Abdominal examination shows diffuse tenderness and ascites. Laboratory findings: WBC 16,200/μL, total bilirubin 4.2 mg/dL, albumin 2.1 g/dL, creatinine 2.8 mg/dL (baseline 1.2), lactate 5.1 mmol/L, INR 2.8. Ascitic fluid analysis shows PMNL count 350/μL, protein 1.2 g/dL, and culture is pending. What is the most appropriate next step?

Explanation

## Clinical Diagnosis: Spontaneous Bacterial Peritonitis (SBP) with Septic Shock This patient has SBP (fever, abdominal pain, ascites with PMNL >250/μL) complicated by septic shock (hypotension, elevated lactate, organ dysfunction: AKI, encephalopathy, coagulopathy). ### SBP Diagnostic Criteria | Finding | Threshold | |---------|----------| | Ascitic PMNL count | >250/μL (diagnostic threshold) | | Protein | Usually <1.5 g/dL (low-protein ascites) | | Culture | Often negative (40–50% positivity); does NOT delay treatment | | Positive predictive value of PMNL >250 | ~90% for SBP | **Key Point:** PMNL count 350/μL is diagnostic for SBP. Treatment must begin immediately — do not wait for culture results. ### Antibiotic Choice in SBP **High-Yield:** Third-generation cephalosporins (cefotaxime or ceftriaxone) are first-line for SBP per EASL 2018 and AASLD guidelines: - Cover gram-negative rods (E. coli, Klebsiella) — the most common organisms - Achieve high ascitic fluid penetration - Superior to aminoglycosides (nephrotoxic in cirrhosis) - **Cefotaxime** (2 g IV q8h) and **ceftriaxone** (2 g IV q24h) are both acceptable first-line agents; cefotaxime is cited in many guidelines as the reference standard - **Note on Option D:** Ceftriaxone 1 g IV q12h is a suboptimal dose (standard is 2 g q24h or 1 g q24h); this dosing error makes Option D incorrect regardless of other considerations **Warning:** Piperacillin-tazobactam (Option C) is broader but not standard for uncomplicated SBP; reserved for healthcare-associated or resistant organisms. ### Hemodynamic Management in SBP with Shock **Clinical Pearl:** Cirrhotic patients in septic shock have unique pathophysiology: - Baseline splanchnic vasodilation and reduced effective arterial blood volume - **Terlipressin** (selective V1 agonist) + albumin is the preferred vasopressor strategy in cirrhotic septic shock - Terlipressin reduces portal pressure, improves renal perfusion, and decreases hepatorenal syndrome (HRS) risk - Norepinephrine alone (Option D) does not address splanchnic vasodilation or provide renal protection in this context - Current EASL guidelines support terlipressin + albumin as superior to norepinephrine alone in SBP-associated circulatory dysfunction ### Albumin Infusion **Key Point:** Albumin is mandatory in SBP because: 1. Expands intravascular volume (oncotic effect) 2. Reduces hepatorenal syndrome risk (NNT ~5 in landmark Sort et al. NEJM 1999 trial) 3. Reduces mortality compared to crystalloid alone 4. Dose: 1.5 g/kg on Day 1, then 1 g/kg on Day 3 ### Paracentesis in SBP **High-Yield:** Therapeutic paracentesis in SBP with septic shock: - Reduces intra-abdominal pressure and bacterial load - Improves hemodynamics when ascites is tense - Does NOT replace antibiotics; is adjunctive ### Why Option A is Correct Option A incorporates the three essential elements of SBP septic shock management: 1. **Cefotaxime** — standard first-line antibiotic for SBP (third-generation cephalosporin) 2. **Terlipressin + albumin** — superior vasopressor/volume strategy in cirrhotic septic shock 3. **Paracentesis** — therapeutic drainage reduces bacterial load and intra-abdominal pressure ### Why Other Options Are Wrong - **Option B:** Delaying antibiotics until culture results is dangerous and contradicts guidelines; SBP is treated empirically - **Option C:** Piperacillin-tazobactam is not first-line for community-acquired SBP; FFP transfusion to INR <1.5 is not indicated unless active bleeding; withholding vasopressors is inappropriate in established septic shock - **Option D:** Ceftriaxone dose is suboptimal (1 g q12h instead of 2 g q24h); norepinephrine alone without terlipressin is inferior in cirrhotic shock; "avoid vasopressin" is partially misleading as terlipressin (V1 agonist) is preferred [cite: EASL Clinical Practice Guidelines on Decompensated Cirrhosis 2018; Sort P et al. NEJM 1999; Harrison's Principles of Internal Medicine 21e Ch 370; KD Tripathi Essentials of Medical Pharmacology 8e]